Ingredient record · Diabetes medicine (DPP-4 inhibitor)
Teneligliptin: bans, restrictions and failed batches in India
Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026
No combination containing Teneligliptin is on India's banned-drugs list. 8 batches of medicines containing Teneligliptin failed a government lab test between August 2022 and May 2026, from 6 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
On the banned-drugs list
Teneligliptin on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
No entry containing Teneligliptin is on the list compiled from CDSCO's Section 26A notifications (1983 to 2026). That is not a statement that every product containing it is safe.
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Teneligliptin Metformin Hydrochloride | 5 | 3 | May 2026 |
| Teneligliptin | 2 | 2 | Jan 2023 |
| Ziten | 1 | 1 | Apr 2023 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Teneligliptin & Metformin Hydrochloride Extended Release tablets IP | T-2503098Mfg 2025-03 · Exp 2027-02 | Rivpra Formulation Pvt. LtdUttarakhand | The sample does not conform to I.P. with respect to the Dissolution and Assay of TeneligliptinAssay | CDL, KolkataCDSCO lab | May 2026 |
| Teneligliptin & Metformin Hydrochloride Extended-release Tablets 20mg and 500mg | T-2406105Mfg 2024-06 · Exp 2026-05 | Rivpra Formulation Pvt. LtdUttarakhand | The sample received does not conform to I.P. 2022 with respect to the test of Dissolution (Teneligliptin) and Assay /Content of TeneligliptinAssay | CDTL, MumbaiCDSCO lab | Jan 2026 |
| Teneligliptin & Metformin Hydrochloride Extended-release Tablets 20mg and 500mg | T-2509069Mfg 2025-09 · Exp 2027-08 | Rivpra Formulation Pvt. LtdUttarakhand | The sample received does not conform to I.P. 2022 with respect to the test for Dissolution (Teneligliptin)Dissolution | CDTL, MumbaiCDSCO lab | Jan 2026 |
| Teneligliptin & Metformin Hydrochloride (Sustained Release) Tablets IP (Teglisure-M 500) | AOT244-00BMfg 2024-03 · Exp 2026-02 | Astonea Labs Pvt. LtdHaryana | Assay/content of TeneligliptinAssay | CDL KolkataCDSCO lab | Apr 2025 |
| Teneligliptin & Metformin Hydrochloride Extended Release Tablets IP (20 mg / 500 mg) | ST23-2897Mfg 2023-10 · Exp 2025-09 | Salud Care (I) Pvt. LtdUttarakhand | Description & Assay of Teneligliptin Hydrobromid e HydrateAssay | CDL KolkataCDSCO lab | Jul 2024 |
| Ziten Tablets (Teneligliptin Tablets IP 20 mg) | 18220672Mfg 2022-09 · Exp 2024-08 | Glenmark Pharmaceuticals LtdSikkim | DissolutionDissolution | CDTL ChennaiCDSCO lab | Apr 2023 |
| Teneligliptin Tablets I.P. 20mg (ZITEN) | 18220490Mfg 2022-07 · Exp 2024-06 | Daffodills Pharmaceuticals LtdUttar Pradesh | DissolutionDissolution | CDTL HyderabadCDSCO lab | Jan 2023 |
| TENELIGLIPTIN TABLETS I.P. 20mg (ZITEN�) | 18211147Mfg 2021-12 · Exp 2023-11 | Glenmark Pharmaceuticals Ltd. Samlik MarchakSikkim | DissolutionDissolution | CDTL HyderabadCDSCO lab | Aug 2022 |
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.